Stereotactic radiosurgery offers long-term tumor control for craniopharyngioma: a multi-institutional analysis of clinical and imaging outcomes from the International Radiosurgery Research Foundation (IRRF)

A. Niranjan J. Reyes Constantinos G. Hadjipanayis K. Bernstein Herwin Speckter Ivan Gonzalez T. Chytka R. Liscak G. Bowden Takuma Sumi Kentaro Narita H. Kano N. Martínez-Moreno R. Martínez-Álvarez P. Picozzi A. Franzini M. Tripathi A. Rai Narendra Kumar K. Douri David Mathieu A. Dono Christian Amezquita-Contreras A. Blanco Y. Esquenazi S. Tos G. Mantziaris S. Peker Y. Samancı A. H. Duzkalir Ying Meng Jason P. Sheehan Douglas Kondziolka L. Lunsford

Aug 2026 · Journal of Neuro-Oncology · Vol 179 · 1 citation · 19 references

Medicine

TL;DR

A retrospective multi-institutional cohort study including 296 patients from 13 centers, SRS achieved durable long-term control with favorable survival and low incidence of visual and endocrinologic dysfunction.

DOI PubMed Semantic Scholar

View source

Similar papers

Open access Sep 2026

Linac-based stereotactic radiosurgery for brain metastases: Survival and salvage treatment in a contemporary cohort of 3893 patients

Abstract Background Real-world outcomes after stereotactic radiosurgery (SRS) for brain metastases across the full burden spectrum are limited. We tested whether overall survival (OS) in higher-burden lesion groups is non-inferior to a 5-10 lesion reference and characterized salvage patterns, including whole-brain radi...

Drew T. Bergman, M. Parker, H. Walch et al. · Neuro-Oncology Advances · 0 citations

Sep 2026

Stereotactic radiosurgery for brain metastases from male breast cancer: a multicenter retrospective study

A. H. Duzkalir, M. O. Askeroglu, D. C. Yildirim et al. · Journal of Neuro-Oncology · 0 citations

Open access Sep 2026

Results of Stereotactic Radiosurgery for Renal Cell Carcinoma Brain Metastases: A Retrospective Single-Center Study

Introduction: Renal cell carcinoma brain metastases are a complication of oncological disease and are associated with an unfavorable prognosis. Stereotactic radiosurgery is one of the main methods of local treatment for intracranial metastases. Data on its outcomes in renal cell carcinoma brain metastases in Kazakhstan...

Zhanerke Abisheva, Z. Gapbas, N. Sygai et al. · Oncology, Nuclear Medicine a... · 0 citations

Open access Oct 2026

CyberKnife Stereotactic Body Radiotherapy for Reirradiation of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Outcomes and Prognostic Factors.

BACKGROUND Stereotactic body radiotherapy (SBRT) is used for reirradiation in recurrent or metastatic head and neck squamous cell carcinoma (RM-HNSCC), but prognostic factors remain unclear. METHODS We retrospectively analyzed 36 RM-HNSCC patients treated with CyberKnife-SBRT (2009-2022). ENDPOINTS local control (L...

Shay Sharon, M. M. Qureshi, S. Keohan et al. · Head and Neck · 0 citations

Review Open access Oct 2026

Clinical outcomes of patients with brain metastases from colorectal cancer treated with stereotactic radiosurgery.

Patients with brain metastases from CRC demonstrate higher LF after SRS compared with other primary sites, highlighting the radioresistant biology of this histology.

A. Bommireddy, Cole Billena, S. Chao et al. · Neuro-Oncology Practice · 0 citations

Open access Sep 2026

Optimal timing of stereotactic radiosurgery with first-line osimertinib in EGFR-mutant non-small cell lung cancer brain metastases: Immediate, early-consolidation and salvage strategies

The optimal timing for integrating stereotactic radiosurgery (SRS) with first-line osimertinib in EGFR-mutant non-small cell lung cancer (NSCLC) with brain metastases (BMs) is undefined. The present study compared outcomes of three distinct SRS timing strategies. In the present dual-center retrospective study, patients...

Xiao-Na Zhuang, Xiao-Xiao Lu, J. Miao et al. · Oncology Letters · 0 citations